Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study

Ralph A Defronzo, M. A. Banerji, G. A. Bray, T. A. Buchanan, S. Clement, R. R. Henry, A. E. Kitabchi, S. Mudaliar, Nicolas Musi, R. Ratner, P. Reaven, D. C. Schwenke, F. D. Stentz, Devjit Tripathy

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Aims/hypothesis: The aim of the study was to examine the determinants of oral glucose tolerance in 602 persons with impaired glucose tolerance (IGT) who participated in the Actos Now for Prevention of Diabetes (ACT NOW) study. Methods: In addition to the 602 IGT participants, 115 persons with normal glucose tolerance (NGT) and 50 with impaired fasting glucose (IFG) were identified during screening and included in this analysis. Insulin secretion and insulin sensitivity indices were derived from plasma glucose and insulin during an OGTT. The acute insulin response (AIR) (0-10 min) and insulin sensitivity (SI) were measured with the frequently sampled intravenous glucose tolerance test (FSIVGTT) in a subset of participants. Results: At baseline, fasting plasma glucose, 2 h postprandial glucose (OGTT) and HbA1c were 5.8 ± 0.02 mmol/l, 10.5 ± 0.05 mmol/l and 5.5 ± 0.04%, respectively, in participants with IGT. Participants with IGT were characterised by defects in early (ΔI 0-30/ΔG 0-30 × Matsuda index, where ΔI is change in insulin in the first 30 min and ΔG is change in glucose in the first 30 min) and total (ΔI0-120/ΔG0-120 × Matsuda index) insulin secretion and in insulin sensitivity (Matsuda index and SI). Participants with IGT in whom 2 h plasma glucose was 7.8-8.3 mmol/l had a 63% decrease in the insulin secretion/insulin resistance (disposition) index vs participants with NGT and this defect worsened progressively as 2 h plasma glucose rose to 8.9-9.94 mmol/l (by 73%) and 10.0-11.05 mmol/l (by 80%). The Matsuda insulin sensitivity index was reduced by 40% in IGT compared with NGT (p < 0.005). In multivariate analysis, beta cell function was the primary determinant of glucose AUC during OGTT, explaining 62% of the variance. Conclusion: Our results strongly suggest that progressive beta cell failure is the main determinant of progression of NGT to IGT.

Original languageEnglish (US)
Pages (from-to)435-445
Number of pages11
JournalDiabetologia
Volume53
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

pioglitazone
Glucose Intolerance
Glucose
Glucose Tolerance Test
Insulin Resistance
Insulin
Fasting

Keywords

  • ACT NOW
  • Impaired fasting glucose
  • Impaired glucose tolerance
  • Insulin resistance
  • Insulin secretion
  • Normal glucose tolerance
  • Type 2 diabetes pathogenesis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. / Defronzo, Ralph A; Banerji, M. A.; Bray, G. A.; Buchanan, T. A.; Clement, S.; Henry, R. R.; Kitabchi, A. E.; Mudaliar, S.; Musi, Nicolas; Ratner, R.; Reaven, P.; Schwenke, D. C.; Stentz, F. D.; Tripathy, Devjit.

In: Diabetologia, Vol. 53, No. 3, 03.2010, p. 435-445.

Research output: Contribution to journalArticle

Defronzo, RA, Banerji, MA, Bray, GA, Buchanan, TA, Clement, S, Henry, RR, Kitabchi, AE, Mudaliar, S, Musi, N, Ratner, R, Reaven, P, Schwenke, DC, Stentz, FD & Tripathy, D 2010, 'Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study', Diabetologia, vol. 53, no. 3, pp. 435-445. https://doi.org/10.1007/s00125-009-1614-2
Defronzo, Ralph A ; Banerji, M. A. ; Bray, G. A. ; Buchanan, T. A. ; Clement, S. ; Henry, R. R. ; Kitabchi, A. E. ; Mudaliar, S. ; Musi, Nicolas ; Ratner, R. ; Reaven, P. ; Schwenke, D. C. ; Stentz, F. D. ; Tripathy, Devjit. / Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. In: Diabetologia. 2010 ; Vol. 53, No. 3. pp. 435-445.
@article{4a55d1f43ed54eda976489851efa87b7,
title = "Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study",
abstract = "Aims/hypothesis: The aim of the study was to examine the determinants of oral glucose tolerance in 602 persons with impaired glucose tolerance (IGT) who participated in the Actos Now for Prevention of Diabetes (ACT NOW) study. Methods: In addition to the 602 IGT participants, 115 persons with normal glucose tolerance (NGT) and 50 with impaired fasting glucose (IFG) were identified during screening and included in this analysis. Insulin secretion and insulin sensitivity indices were derived from plasma glucose and insulin during an OGTT. The acute insulin response (AIR) (0-10 min) and insulin sensitivity (SI) were measured with the frequently sampled intravenous glucose tolerance test (FSIVGTT) in a subset of participants. Results: At baseline, fasting plasma glucose, 2 h postprandial glucose (OGTT) and HbA1c were 5.8 ± 0.02 mmol/l, 10.5 ± 0.05 mmol/l and 5.5 ± 0.04{\%}, respectively, in participants with IGT. Participants with IGT were characterised by defects in early (ΔI 0-30/ΔG 0-30 × Matsuda index, where ΔI is change in insulin in the first 30 min and ΔG is change in glucose in the first 30 min) and total (ΔI0-120/ΔG0-120 × Matsuda index) insulin secretion and in insulin sensitivity (Matsuda index and SI). Participants with IGT in whom 2 h plasma glucose was 7.8-8.3 mmol/l had a 63{\%} decrease in the insulin secretion/insulin resistance (disposition) index vs participants with NGT and this defect worsened progressively as 2 h plasma glucose rose to 8.9-9.94 mmol/l (by 73{\%}) and 10.0-11.05 mmol/l (by 80{\%}). The Matsuda insulin sensitivity index was reduced by 40{\%} in IGT compared with NGT (p < 0.005). In multivariate analysis, beta cell function was the primary determinant of glucose AUC during OGTT, explaining 62{\%} of the variance. Conclusion: Our results strongly suggest that progressive beta cell failure is the main determinant of progression of NGT to IGT.",
keywords = "ACT NOW, Impaired fasting glucose, Impaired glucose tolerance, Insulin resistance, Insulin secretion, Normal glucose tolerance, Type 2 diabetes pathogenesis",
author = "Defronzo, {Ralph A} and Banerji, {M. A.} and Bray, {G. A.} and Buchanan, {T. A.} and S. Clement and Henry, {R. R.} and Kitabchi, {A. E.} and S. Mudaliar and Nicolas Musi and R. Ratner and P. Reaven and Schwenke, {D. C.} and Stentz, {F. D.} and Devjit Tripathy",
year = "2010",
month = "3",
doi = "10.1007/s00125-009-1614-2",
language = "English (US)",
volume = "53",
pages = "435--445",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study

AU - Defronzo, Ralph A

AU - Banerji, M. A.

AU - Bray, G. A.

AU - Buchanan, T. A.

AU - Clement, S.

AU - Henry, R. R.

AU - Kitabchi, A. E.

AU - Mudaliar, S.

AU - Musi, Nicolas

AU - Ratner, R.

AU - Reaven, P.

AU - Schwenke, D. C.

AU - Stentz, F. D.

AU - Tripathy, Devjit

PY - 2010/3

Y1 - 2010/3

N2 - Aims/hypothesis: The aim of the study was to examine the determinants of oral glucose tolerance in 602 persons with impaired glucose tolerance (IGT) who participated in the Actos Now for Prevention of Diabetes (ACT NOW) study. Methods: In addition to the 602 IGT participants, 115 persons with normal glucose tolerance (NGT) and 50 with impaired fasting glucose (IFG) were identified during screening and included in this analysis. Insulin secretion and insulin sensitivity indices were derived from plasma glucose and insulin during an OGTT. The acute insulin response (AIR) (0-10 min) and insulin sensitivity (SI) were measured with the frequently sampled intravenous glucose tolerance test (FSIVGTT) in a subset of participants. Results: At baseline, fasting plasma glucose, 2 h postprandial glucose (OGTT) and HbA1c were 5.8 ± 0.02 mmol/l, 10.5 ± 0.05 mmol/l and 5.5 ± 0.04%, respectively, in participants with IGT. Participants with IGT were characterised by defects in early (ΔI 0-30/ΔG 0-30 × Matsuda index, where ΔI is change in insulin in the first 30 min and ΔG is change in glucose in the first 30 min) and total (ΔI0-120/ΔG0-120 × Matsuda index) insulin secretion and in insulin sensitivity (Matsuda index and SI). Participants with IGT in whom 2 h plasma glucose was 7.8-8.3 mmol/l had a 63% decrease in the insulin secretion/insulin resistance (disposition) index vs participants with NGT and this defect worsened progressively as 2 h plasma glucose rose to 8.9-9.94 mmol/l (by 73%) and 10.0-11.05 mmol/l (by 80%). The Matsuda insulin sensitivity index was reduced by 40% in IGT compared with NGT (p < 0.005). In multivariate analysis, beta cell function was the primary determinant of glucose AUC during OGTT, explaining 62% of the variance. Conclusion: Our results strongly suggest that progressive beta cell failure is the main determinant of progression of NGT to IGT.

AB - Aims/hypothesis: The aim of the study was to examine the determinants of oral glucose tolerance in 602 persons with impaired glucose tolerance (IGT) who participated in the Actos Now for Prevention of Diabetes (ACT NOW) study. Methods: In addition to the 602 IGT participants, 115 persons with normal glucose tolerance (NGT) and 50 with impaired fasting glucose (IFG) were identified during screening and included in this analysis. Insulin secretion and insulin sensitivity indices were derived from plasma glucose and insulin during an OGTT. The acute insulin response (AIR) (0-10 min) and insulin sensitivity (SI) were measured with the frequently sampled intravenous glucose tolerance test (FSIVGTT) in a subset of participants. Results: At baseline, fasting plasma glucose, 2 h postprandial glucose (OGTT) and HbA1c were 5.8 ± 0.02 mmol/l, 10.5 ± 0.05 mmol/l and 5.5 ± 0.04%, respectively, in participants with IGT. Participants with IGT were characterised by defects in early (ΔI 0-30/ΔG 0-30 × Matsuda index, where ΔI is change in insulin in the first 30 min and ΔG is change in glucose in the first 30 min) and total (ΔI0-120/ΔG0-120 × Matsuda index) insulin secretion and in insulin sensitivity (Matsuda index and SI). Participants with IGT in whom 2 h plasma glucose was 7.8-8.3 mmol/l had a 63% decrease in the insulin secretion/insulin resistance (disposition) index vs participants with NGT and this defect worsened progressively as 2 h plasma glucose rose to 8.9-9.94 mmol/l (by 73%) and 10.0-11.05 mmol/l (by 80%). The Matsuda insulin sensitivity index was reduced by 40% in IGT compared with NGT (p < 0.005). In multivariate analysis, beta cell function was the primary determinant of glucose AUC during OGTT, explaining 62% of the variance. Conclusion: Our results strongly suggest that progressive beta cell failure is the main determinant of progression of NGT to IGT.

KW - ACT NOW

KW - Impaired fasting glucose

KW - Impaired glucose tolerance

KW - Insulin resistance

KW - Insulin secretion

KW - Normal glucose tolerance

KW - Type 2 diabetes pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=77949270229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949270229&partnerID=8YFLogxK

U2 - 10.1007/s00125-009-1614-2

DO - 10.1007/s00125-009-1614-2

M3 - Article

C2 - 20012012

AN - SCOPUS:77949270229

VL - 53

SP - 435

EP - 445

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 3

ER -